Facial bite wounds: management update.
Bite wounds are frequently located on the face; injuries inflicted by dogs are most common, especially in children. Bacteriology of infected dog and cat bite wounds includes Pasteurella multocida, Staphylococcus aureus, viridans streptococci, Capnocytophaga canimorsus, and oral anaerobes. Infected human bites yield a similar spectrum of bacteria except for Pasteurellae and C. canimorsus; instead human bites are frequently complicated by Eikenella corrodens. Antibiotic therapy against these bacteria is indicated both for infected bite wounds and fresh wounds considered at risk for infection. Amoxicillin-clavulanate (and other combinations of extended-spectrum penicillins with beta-lactamase inhibitors) and moxifloxacin offer the best in vitro coverage of the pathogenic flora. Initial wound management consisting in irrigation and debridement is at least equally important with antibiotics for prevention of infection. The need for prophylaxis against systemic infectious complications, particularly tetanus, should also be evaluated. Primary surgical repair is the treatment of choice for most clinically uninfected facial bite wounds, whereas delayed closure should be reserved for certain high risk or already infected wounds. Avulsive injuries with significant tissue loss represent the most difficult cases for definitive management and are also those most likely to require hospitalization.
Stefanopoulos
P K
PK
Department of Oral and Maxillofacial Surgery, 401 General Army Hospital, Athens, Greece.
Tarantzopoulou
A D
AD
D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001733:Bites and Stings / Q000382:microbiology / Q000601:surgery / Q000628:therapy*; D001734:Bites, Human / Q000382:microbiology / Q000601:surgery / Q000628:therapy; D002415:Cats; D004285:Dogs; D005151:Facial Injuries / Q000382:microbiology / Q000601:surgery / Q000628:therapy*; D006801:Humans; D014946:Wound Infection / Q000517:prevention & control
D000900:Anti-Bacterial Agents